Why sex alone cannot explain cannabis impairment or toxicity
Sex-related differences in psychoactive drug toxicology: Implications and limitations for forensic interpretation.
AI Summary
This review examines whether biological sex affects how psychoactive drugs are processed and how they influence the bodyβan issue that can matter when forensic experts interpret blood or tissue concentrations after suspected impairment, poisoning, or death. The authors assess evidence across several drug classes, including cannabinoids, opioids, sedative-hypnotics, antidepressants, antipsychotics, and stimulants. They conclude that sex may influence drug concentrations, metabolite patterns, adverse effects, and pharmacodynamic responses, although findings are often inconsistent or confounded by factors such as body size, age, hormonal status, tolerance, route of administration, and other medications.
For cannabis-related interpretation, the reviewβs message is one of caution: sex may be relevant, but it cannot reliably determine impairment or toxicity on its own. The authors do not support universal sex-specific correction factors for toxicology results. Instead, sex should be considered alongside measured concentration, specimen type, timing and route of use, tolerance, other drugs, medical history, autopsy findings, and the surrounding investigation. The abstract reports no quantitative cannabis-specific results, so it does not establish a predictable sex-based difference in cannabis effects or toxicology.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Review finds mixed evidence on cannabis and tobacco co-use effects
Review finds promise in acidic cannabinoids, but human benefits remain unproven
A cancer-pain case report raises concern about THC/CBD with opioids
Explore More Research
Stay informed about the latest cannabis science.